Lipidomics-based natural products for chronic kidney disease treatment
Chronic kidney disease (CKD) is by far the most prevalent disease in the world and is now a major global public health problem because of the increase in diabetes, hypertension and obesity. Traditional biomarkers of kidney function lack sensitivity and specificity for early detection and monitoring...
Saved in:
| Main Authors: | Rui Zhang, Jingjing Wang, Chenguang Wu, Lifan Wang, Peng Liu, Ping Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024176517 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Causal role of the plasma lipidome in the occurrence and progression of chronic kidney disease: a two-sample Mendelian randomization study
by: Jiaming Su, et al.
Published: (2025-06-01) -
Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications
by: Sijia He, et al.
Published: (2025-01-01) -
Lipidomics Unveils Critical Lipid Pathway Shifts in Alport Syndrome
by: Belen Requena, et al.
Published: (2025-08-01) -
Effects of diet and development on the Drosophila lipidome
by: Maria Carvalho, et al.
Published: (2012-07-01) -
Targeted lipidomics analysis of possible molecular mechanisms of lipid changes in temporal lobe epilepsy models
by: Huaiyu Sun, et al.
Published: (2025-01-01)